CD34 and acute myeloid leukemia: As with the activity of hematopoietic stem cells, the LSC activity in some specific subtypes of AML are also contained within the CD34+ fraction of AML cells (18–22), making it a fundamental stem cell marker for both HSCs and LSCs.